Atlas Trials

Aperta Biosciences, LLC

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aperta Biosciences, LLC

RecordFirmDate
A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis. (NCT06720896)Aperta Biosciences, LLC2025-11-01

Track Aperta Biosciences, LLC automatically

Every clearance here is in the API, with alerts when new ones post.